- CATIE NewsA Vancouver study piloted combined pre-exposure prophylaxis (PrEP) for HIV and bacterial STIs. In addition to HIV PrEP, participants were offered doxycycline PrEP at different stages of the trial.…
- Client PublicationIllegal drugs are not regulated, meaning there are no rules or standards for what is in them or how strong they are. Here’s why that makes the drug supply dangerous: Unknown and unpredictable…
- Placeholder
- Prevention in FocusThis article outlines lessons learned from GetCheckedOnline, a digital testing service for STBBIs.
- WebinarThis webinar explores disparities in post-release hepatitis C care across provinces, as well as system-level and program-level approaches to strengthening linkage to care through the transition from…
- CATIE NewsSwiss researchers monitored nearly 15,000 people living with HIV for interruptions to HIV care. 19% had their care interrupted, and upon re-engagement, many had a weakened immune system.…
- WebinarThis session highlights diverse approaches to improving PrEP uptake among ACB communities, including heterosexual men and women, as well as gay, bisexual and other men who have sex with men. It also…
- Prevention in FocusAn overview of Canadian resources and tools on harm reduction for gay, bisexual and other men who have sex with men (gbMSM) and for service providers who support them.
- CATIE NewsB.C. researchers studied opioid agonist therapy during incarceration and non-fatal overdose after release. OAT medications like methadone or buprenorphine help to manage opioid withdrawal symptoms.…
- CATIE NewsLong-acting HIV pre-exposure prophylaxis (PrEP) is now covered by some drug plans in Canada. Cabotegravir is the first long-acting injectable form of PrEP approved by Health Canada. This highly…